Cairncross, J. G., Wang, M., Jenkins, R. B., Shaw, E. G., Giannini, C., Brachman, D. G., . . . Curran, W. J. (2014). Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. American Society of Clinical Oncology.
Chicago-стиль цитированияCairncross, J. Gregory, et al. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. American Society of Clinical Oncology, 2014.
MLA-цитированиеCairncross, J. Gregory, et al. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. American Society of Clinical Oncology, 2014.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.